Advanz To Adopt European Legal Domicile

Switching Base From Canada To Jersey

 
• By Aidan Fry
  
Generate a summary of this article
Listen to this article
Beta

In a move expected to unlock operational and cost efficiencies, Advanz Pharma is moving its legal and tax domicile to Jersey, close to its strategic focus on western European markets.

Jersey
Advanz Pharma has received shareholder clearance to move its tax and legal domicile to Jersey • Source: Shutterstock

Advanz Pharma’s shareholders have voted overwhelmingly to relocate the company’s legal domicile to Jersey in the Channel Islands, prospectively making the group a resident of the UK for tax purposes. The niche established medicines specialist said 97.3% of its shareholders had voted in favor of a special resolution approving the “continuance of the company” from its current corporate headquarters in Toronto, Canada to Jersey.

While as a consequence of its emergence from the legacy Concordia organization, Advanz currently has its legal and tax domicile...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Legal & IP

  • ADHD

    This is regarding ADHD.

  • GB-Leadership-Free: Article with 150 words (Time to read is < 1 min)

     
    • By Nabil

    In the first cinematic chapter of J.K. Rowling’s wizarding world, young Harry Potter discovers his true identity and enters Hogwarts School of Witchcraft and Wizardry. This enchanting origin story sets the tone for a saga filled with magic, loyalty, and the power of choice.

  • MPP Finds Three More Partners On Key Hepatitis C Treatment

     
    • By Akriti Seth

    The Medicines Patent Pool has entered into a partnership with three companies for glecaprevir/pibrentasvir, a WHO-recommended treatment for people living with hepatitis C. The companies join previous generic licensee Mylan and originator AbbVie.

  • Troubled Teligent Enters Bankruptcy Proceedings As CEO Resigns

     
    • By David Wallace

    Teligent is pursuing an asset sale process to “maximize the value of the company” after entering into Chapter 11 bankruptcy proceedings in the US. The firm – which has also seen CEO Tim Sawyer resign – had been struggling of late with remediation issues to address a warning letter at its Buena manufacturing facility in New Jersey, as well as a recent recall.

More from Generics Bulletin